-
AstraZeneca
AstraZeneca awarded over $360,000 to Dana-Farber to appoint a patient navigator to expand equitable access to clinical trials within the Breast Oncology Research Program. This navigator will proactively engage with patients with breast cancer and will focus on outreach and education to patients from historically marginalized communities to help navigate clinical trial complexities, logistics, and…
-
Breast Cancer Alliance
The Breast Cancer Alliance awarded a 2024 Young Investigator Grant of $125,000 to Sarah Naomi Olsen, PhD, accelerating her research on chromatin complexes in estrogen receptor-positive breast cancer. This impactful award will deepen our understanding of these unique complexes, laying the groundwork for new treatments which could significantly improve patient care.
-
Cancer Nutrition Consortium
The Cancer Nutrition Consortium awarded $110,000 to Dana-Farber to develop and test personalized nutrition plans for patients with cancer, aiming to improve their quality of life. This study will build on the guidelines previously established by the Cancer Nutrition Consortium.
-
For Kids’ Sake Foundation
The For Kids’ Sake Foundation has generously donated $200,000 to establish the Malia’s Legacy Loves On Fellowship at Dana-Farber, in honor of Malia Jusczyk. This two-year fellowship, managed by Robbie Majzner, MD, will support neuroblastoma research focusing on enhancing GD2-targeted therapies and overcoming treatment resistance.
-
Harrington Discovery Institute
With a generous $460,000 contribution, the Harrington Discovery Institute is propelling innovative cancer research led by Min-Ru Wu, MD, PhD, and Loren Walensky, MD, PhD, as they work to develop less toxic treatments for melanoma patients and investigate targeted therapies for other drug-resistant cancers, respectively.
-
Jimmy Fund Day at Fenway
Jimmy Fund Day at Fenway presented by DraftKings raised $230,000 to support innovative cancer research and compassionate patient care at Dana-Farber. Thanks to donor support, Dana-Farber patients and their families were able to participate in this unforgettable experience and take the field at Fenway Park.
-
The Lewin Fund to Fight Women’s Cancers
The Lewin Fund to Fight Women’s Cancers committed $300,000 to advancing clinical trials led by Joyce Liu, MD, MPH, and Elizabeth Lee, MD. This support will propel investigations in uterine papillary serous carcinoma and HER2-expressing malignancies, with the potential to elevate advances in gynecologic oncology research for all patients.
-
Dr. Gerald and Mrs. Mary McGillicuddy
Dr. Gerald and Mrs. Mary McGillicuddy made a $100,000 gift to support the work of Julia Rotow, MD, a researcher in the Lowe Center for Thoracic Oncology at Dana-Farber. With this gift, Rotow and her team will work to develop better, more effective targeted and immunotherapy options for patients with lung cancer.
-
The Norman J. Fisher & Doris Fisher Foundation
The Norman J. Fisher & Doris Fisher Foundation recently renewed their support for the Michael C. Gohl Fellowship with a generous $350,000 gift. This fellowship in thoracic oncology supports a promising early career scientist working in the lab of Pasi Jänne, MD, PhD.
-
The Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network recently awarded $400,000 in grant funding to Institute researchers Julien Dilly, MS, and William Freed-Pastor, MD, PhD, to better understand mechanisms of response and resistance to KRAS inhibition in pancreatic cancer and improve existing pre-clinical models for this intractable disease.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.